Infant Formula DHA Algae Oil

Global Infant Formula DHA Algae Oil Market to Reach US$506.4 Million by 2030

The global market for Infant Formula DHA Algae Oil estimated at US$356.3 Million in the year 2024, is expected to reach US$506.4 Million by 2030, growing at a CAGR of 6.0% over the analysis period 2024-2030. 30% - 40%, one of the segments analyzed in the report, is expected to record a 7.0% CAGR and reach US$353.2 Million by the end of the analysis period. Growth in the 40% - 50% segment is estimated at 4.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$97.1 Million While China is Forecast to Grow at 9.7% CAGR

The Infant Formula DHA Algae Oil market in the U.S. is estimated at US$97.1 Million in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$104.2 Million by the year 2030 trailing a CAGR of 9.7% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.9% and 6.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.0% CAGR.

Global Infant Formula DHA Algae Oil Market – Key Trends & Drivers Summarized

Infant Formula DHA Algae Oil: The Future of Infant Nutrition?

The market for Infant Formula DHA Algae Oil has gained significant traction over the past decade as awareness surrounding the benefits of Docosahexaenoic Acid (DHA) in infant development continues to rise. DHA, a critical omega-3 fatty acid, plays a vital role in brain and visual development, making its inclusion in infant formula essential for proper growth. Traditionally, DHA was sourced from fish oil; however, concerns over contamination, sustainability, and dietary preferences have propelled the demand for algae-derived DHA as a cleaner, plant-based alternative. Algae oil provides a sustainable and pure source of DHA without the risk of heavy metal exposure, making it the preferred choice for infant formula manufacturers worldwide.

Regulatory changes have also significantly influenced the market, with various health organizations, including the World Health Organization (WHO) and the Food and Drug Administration (FDA), emphasizing the necessity of DHA supplementation in infant nutrition. As a result, manufacturers are increasingly incorporating algae-derived DHA into their formulas to comply with new regulations and meet growing consumer expectations. The shift towards plant-based nutrition has further accelerated demand, as parents seek healthier, vegan-friendly options for their children. Additionally, advancements in extraction and purification technologies are enhancing the quality and efficacy of algae-derived DHA, further boosting its adoption in the infant formula sector.

Why Is Algae Oil DHA Becoming the Preferred Choice for Infant Formula?

One of the major factors driving the preference for algae oil DHA in infant formula is its sustainability and purity compared to fish oil. Unlike fish-derived DHA, which carries the risk of oceanic pollutants and fluctuating supply due to overfishing, algae oil is cultivated in controlled environments, ensuring a consistent and contaminant-free product. This makes it an attractive choice for formula manufacturers looking to provide the highest quality nutrition while adhering to strict safety standards. Furthermore, algae oil is rich in DHA while being free from common allergens, making it suitable for infants with dietary sensitivities.

The growing demand for plant-based and vegan-friendly alternatives has further propelled the shift towards algae-derived DHA. As more parents adopt plant-based diets for ethical and environmental reasons, the need for non-animal-derived DHA sources has surged. Infant formula brands are responding to this trend by reformulating their products to include algae oil DHA, ensuring they cater to a broader demographic. The technological advancements in algae cultivation and oil extraction are also improving the bioavailability and stability of DHA, allowing for better absorption and prolonged shelf life in infant formula products.

Another significant factor contributing to the rise of algae oil DHA is its superior taste and odor profile. Fish oil DHA often imparts an unpleasant aftertaste to infant formulas, which can affect palatability and lead to feeding issues. Algae oil, on the other hand, is neutral in taste and smell, making it easier to incorporate into formula without compromising the overall sensory experience. This has encouraged leading infant formula manufacturers to transition from fish-based DHA to algae-based alternatives to enhance product acceptance among both infants and parents.

What Are the Technological Advancements Shaping the Market?

The infant formula DHA algae oil market has benefited from continuous innovation in microalgae cultivation and oil extraction processes. One of the most notable advancements is the use of closed-loop fermentation systems, which enable large-scale, high-purity DHA production with minimal environmental impact. Unlike traditional open-pond cultivation, which is susceptible to contamination and variability, closed-loop systems provide a controlled environment that optimizes algae growth, enhances yield, and ensures consistency in DHA concentration.

In addition to cultivation improvements, breakthroughs in oil extraction and purification have played a crucial role in refining algae oil DHA for infant formula applications. Supercritical CO2 extraction, for instance, has emerged as a preferred method for obtaining DHA-rich algae oil while preserving its nutritional integrity. This technique eliminates the need for chemical solvents, resulting in a cleaner, more sustainable product. Furthermore, encapsulation technologies are being employed to enhance DHA stability, preventing oxidation and degradation during formula processing and storage.

The adoption of precision fermentation techniques is another key development reshaping the industry. This cutting-edge technology allows for the bioengineering of microalgae strains to maximize DHA output while reducing production costs. As a result, the affordability of algae-derived DHA is improving, making it more accessible for large-scale infant formula manufacturing. Additionally, research in lipid optimization is leading to the development of enhanced DHA formulations that improve absorption and efficacy, ensuring optimal health benefits for infants consuming DHA-enriched formulas.

What Is Driving the Growth of the Infant Formula DHA Algae Oil Market?

The growth in the infant formula DHA algae oil market is driven by several factors, including technological advancements, the shift towards plant-based nutrition, and the increasing regulatory emphasis on DHA supplementation in infant diets. One of the primary drivers is the rising awareness of DHA’s critical role in cognitive and visual development, prompting parents and healthcare providers to prioritize formulas fortified with high-quality DHA sources. Algae-derived DHA meets this demand by offering a highly bioavailable, pure, and sustainable alternative to traditional fish oil sources.

The surge in demand for clean-label and allergen-free infant nutrition is also contributing to market expansion. With a growing number of parents seeking transparency in ingredient sourcing and product formulations, manufacturers are focusing on DHA algae oil as a premium, traceable option that aligns with consumer preferences. The trend towards organic and non-GMO infant formulas further strengthens this demand, as algae oil DHA is easily incorporated into such formulations without compromising product integrity.

Additionally, the increasing penetration of premium and specialty infant formula products in emerging markets is fueling industry growth. As disposable incomes rise in countries such as China, India, and Brazil, parents are more willing to invest in high-quality infant nutrition products that incorporate advanced nutritional elements like algae-derived DHA. Strategic partnerships between biotechnology firms and infant formula manufacturers are also accelerating innovation, ensuring that the latest advancements in algae oil DHA production are efficiently integrated into infant nutrition solutions. As these factors continue to shape the market, the adoption of DHA algae oil in infant formula is expected to witness sustained growth, solidifying its position as the preferred choice for infant cognitive and developmental health.

SCOPE OF STUDY:

The report analyzes the Infant Formula DHA Algae Oil market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
Content (30% - 40%, 40% - 50%); Age Group (Below 3 years, 3 - 6 years, Others)

Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 32 Featured) -

• AAK AB
• Algarithm Ingredients Inc.
• Archer Daniels Midland Company (ADM)
• BASF SE
• Cabio Biotech (Wuhan) Co., Ltd.
• Cargill, Incorporated
• Cellana Inc.
• Corbion N.V.
• DSM Nutritional Products
• Far East Microalgae Industries, Co., Ltd.
• Goerlich Pharma GmbH
• Guangdong Runke Bioengineering Co., Ltd.
• HuveNutra
• JC Biotech Pvt. Ltd.
• Kingdomway Nutrition, Inc.
• Lonza Group Ltd.
• Meteoric Biopharmaceuticals Pvt. Ltd.
• Polaris S.A.
• Qingdao Keyuan Marine Biochemistry Co., Ltd.
• Xiamen Huison Biotech Co., Ltd.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA
CHINA
MEXICO
CANADA
EU
JAPAN
INDIA
176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.